Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East - Top-Institutions - MDSpire

Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East

  • By

  • Riad El Fakih

  • Alfadil Haroon

  • Feras Alfraih

  • Murtadha K. Al-Khabori

  • Mohsen Alzahrani

  • Ahmad Alhuraiji

  • Abdulaziz Hamadah

  • Naif I. AlJohani

  • Bader Alahmari

  • Mohammed F. Essa

  • Ibraheem H. Motabi

  • Imran K. Tailor

  • Reem S. Almaghrabi

  • Khalil Al-Farsi

  • Ibraheem Abosoudah

  • Mouhab Ayas

  • Tusneem A. Elhassan

  • Ashraf M. Suhebeh

  • Syed Osman Ahmed

  • Saud Alhayli

  • Panayotis Kaloyannidis

  • Ahmad Alsaeed

  • Khalid Al Anezi

  • Sameer Alamoudi

  • Moussab Damlaj

  • Hani Al Hashmi

  • Mahmoud Aljurf

  • April 27, 2021

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Infectious Diseases
    • Immunology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology/Oncology
    • Hematopoietic Cell Transplantation
    • Infectious Diseases

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Oncology
    • Infectious Diseases

  • #4

    European Society for Blood and Marrow Transplantation (EBMT) - Coordinating Centers
    European Society for Blood and Marrow Transplantation (EBMT) - Coordinating Centers

    Paris, N/A

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Infectious Diseases
    • Epidemiology

  • #5

    King Faisal Specialist Hospital & Research Centre
    King Faisal Specialist Hospital & Research Centre

    Riyadh, Saudi Arabia

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Infectious Diseases

Original Source(s)

Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East

  • by Riad El Fakih, Alfadil Haroon, Feras Alfraih, Murtadha K. Al-Khabori, Mohsen Alzahrani, Ahmad Alhuraiji, Abdulaziz Hamadah, Naif I. AlJohani, Bader Alahmari, Mohammed F. Essa, Ibraheem H. Motabi, Imran K. Tailor, Reem S. Almaghrabi, Khalil Al-Farsi, Ibraheem Abosoudah, Mouhab Ayas, Tusneem A. Elhassan, Ashraf M. Suhebeh, Syed Osman Ahmed, Saud Alhayli, Panayotis Kaloyannidis, Ahmad Alsaeed, Khalid Al Anezi, Sameer Alamoudi, Moussab Damlaj, Hani Al Hashmi, Mahmoud Aljurf

  • April 27, 2021

Related Content

Impact of Antiphospholipid Antibodies on COVID-19 Severity and Patient Outcomes

Normalization of Seasonality and Age Distribution of Pediatric RSV Infection Following the Pandemic Disruption in the Netherlands

Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study